About 1 result found for searched term "Lampalizumab" (0.397 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M24600 | Lampalizumab | Complement System |
| RG 7417; TNX 234; Anti-CFD Recombinant Antibody | ||
| Lampalizumab (RG 7417) is a humanised monoclonal antibody targeting complement Factor D in the alternative complement pathway. Lampalizumab binds an exosite and sterically blocks Factor B access to the active site. Lampalizumab can be used for age-related macular degeneration (AMD) research. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
